Cargando…

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1

PURPOSE: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder associated with cognitive deficits. The NF1 cognitive phenotype is generally considered to be highly variable, possibly due to the observed T2-weighted hyperintensities, loss of heterozygosity, NF1-specific genetic modifiers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottenhoff, Myrthe J., Rietman, André B., Mous, Sabine E., Plasschaert, Ellen, Gawehns, Daniela, Brems, Hilde, Oostenbrink, Rianne, van Minkelen, Rick, Nellist, Mark, Schorry, Elizabeth, Legius, Eric, Moll, Henriette A., Elgersma, Ype
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200599/
https://www.ncbi.nlm.nih.gov/pubmed/32015538
http://dx.doi.org/10.1038/s41436-020-0752-2
_version_ 1783529367871160320
author Ottenhoff, Myrthe J.
Rietman, André B.
Mous, Sabine E.
Plasschaert, Ellen
Gawehns, Daniela
Brems, Hilde
Oostenbrink, Rianne
van Minkelen, Rick
Nellist, Mark
Schorry, Elizabeth
Legius, Eric
Moll, Henriette A.
Elgersma, Ype
author_facet Ottenhoff, Myrthe J.
Rietman, André B.
Mous, Sabine E.
Plasschaert, Ellen
Gawehns, Daniela
Brems, Hilde
Oostenbrink, Rianne
van Minkelen, Rick
Nellist, Mark
Schorry, Elizabeth
Legius, Eric
Moll, Henriette A.
Elgersma, Ype
author_sort Ottenhoff, Myrthe J.
collection PubMed
description PURPOSE: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder associated with cognitive deficits. The NF1 cognitive phenotype is generally considered to be highly variable, possibly due to the observed T2-weighted hyperintensities, loss of heterozygosity, NF1-specific genetic modifiers, or allelic imbalance. METHODS: We investigated cognitive variability and assessed the contribution of genetic factors by performing a retrospective cohort study and a monozygotic twin case series. We included data of 497 children with genetically confirmed NF1 and an IQ assessment, including 12 monozygotic twin and 17 sibling sets. RESULTS: Individuals carrying an NF1 chromosomal microdeletion showed significant lower full-scale IQ (FSIQ) scores than individuals carrying intragenic pathogenic NF1 variants. For the intragenic subgroup, the variability in cognitive ability and the correlation of IQ between monozygotic NF1 twin pairs or between NF1 siblings is similar to the general population. CONCLUSIONS: The variance and heritability of IQ in individuals with NF1 are similar to that of the general population, and hence mostly driven by genetic background differences. The only factor that significantly attenuates IQ in NF1 individuals is the NF1 chromosomal microdeletion genotype. Implications for clinical management are that individuals with intragenic NF1 variants that score <1.5–2 SD below the mean of the NF1 population should be screened for additional causes of cognitive disability.
format Online
Article
Text
id pubmed-7200599
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-72005992020-05-07 Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1 Ottenhoff, Myrthe J. Rietman, André B. Mous, Sabine E. Plasschaert, Ellen Gawehns, Daniela Brems, Hilde Oostenbrink, Rianne van Minkelen, Rick Nellist, Mark Schorry, Elizabeth Legius, Eric Moll, Henriette A. Elgersma, Ype Genet Med Article PURPOSE: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder associated with cognitive deficits. The NF1 cognitive phenotype is generally considered to be highly variable, possibly due to the observed T2-weighted hyperintensities, loss of heterozygosity, NF1-specific genetic modifiers, or allelic imbalance. METHODS: We investigated cognitive variability and assessed the contribution of genetic factors by performing a retrospective cohort study and a monozygotic twin case series. We included data of 497 children with genetically confirmed NF1 and an IQ assessment, including 12 monozygotic twin and 17 sibling sets. RESULTS: Individuals carrying an NF1 chromosomal microdeletion showed significant lower full-scale IQ (FSIQ) scores than individuals carrying intragenic pathogenic NF1 variants. For the intragenic subgroup, the variability in cognitive ability and the correlation of IQ between monozygotic NF1 twin pairs or between NF1 siblings is similar to the general population. CONCLUSIONS: The variance and heritability of IQ in individuals with NF1 are similar to that of the general population, and hence mostly driven by genetic background differences. The only factor that significantly attenuates IQ in NF1 individuals is the NF1 chromosomal microdeletion genotype. Implications for clinical management are that individuals with intragenic NF1 variants that score <1.5–2 SD below the mean of the NF1 population should be screened for additional causes of cognitive disability. Nature Publishing Group US 2020-02-04 2020 /pmc/articles/PMC7200599/ /pubmed/32015538 http://dx.doi.org/10.1038/s41436-020-0752-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ottenhoff, Myrthe J.
Rietman, André B.
Mous, Sabine E.
Plasschaert, Ellen
Gawehns, Daniela
Brems, Hilde
Oostenbrink, Rianne
van Minkelen, Rick
Nellist, Mark
Schorry, Elizabeth
Legius, Eric
Moll, Henriette A.
Elgersma, Ype
Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title_full Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title_fullStr Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title_full_unstemmed Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title_short Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
title_sort examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200599/
https://www.ncbi.nlm.nih.gov/pubmed/32015538
http://dx.doi.org/10.1038/s41436-020-0752-2
work_keys_str_mv AT ottenhoffmyrthej examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT rietmanandreb examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT moussabinee examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT plasschaertellen examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT gawehnsdaniela examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT bremshilde examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT oostenbrinkrianne examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT vanminkelenrick examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT nellistmark examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT schorryelizabeth examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT legiuseric examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT mollhenriettea examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1
AT elgersmaype examinationofthegeneticfactorsunderlyingthecognitivevariabilityassociatedwithneurofibromatosistype1